3-Ethoxy-4-methoxybenzonitrile | CAS:60758-86-3

We serve 3-Ethoxy-4-methoxybenzonitrile CAS:60758-86-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Ethoxy-4-methoxybenzonitrile

CAS No: 60758-86-3
Product Name: 3-Ethoxy-4-methoxybenzonitrile
Other Name:
3-Ethoxy-4-methoxybenzonitrile
3-Aethoxy-4-methoxy-benzonitril
3-Ethoxy-4-methoxybenzenecarbonitrile
4-Methoxy-3-aethoxy-benzoesaeure-nitril
 
Density: 1.1±0.1 g/cm3
Boiling Point: 281.9±25.0 °C at 760 mmHg
Molecular Formula: C10H11NO2
Molecular Weight: 177.200
Flash Point: 109.2±16.4 °C
Exact Mass: 177.078979
PSA: 42.25000
LogP: 2.10
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.515
 
Specification
Appearance: White powder
Assay: ≥99.0%
Loss on drying: ≤0.5%
Sulphate Ash: ≤0.1%
 
Application
Intermediates of Apremilast CAS: 608141-41-9.
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Ethoxy-4-methoxybenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methoxy-3-aethoxy-benzoesaeure-nitril physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Ethoxy-4-methoxybenzonitrile Use and application,3-Ethoxy-4-methoxybenzonitrile technical grade,usp/ep/jp grade.


Related News: The risk to the UK population has been raised from very low to low, according to Public Health England, which says the country is “well prepared for new diseases”.(3R)-1-azabicyclo[2.2.2]octan-3-ol manufacturer The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China.3-fluoro-5-methylbenzaldehyde supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.dCMP vendor In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.